Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Guelph

$24,557.00

Proof of concept of a clinical diagnostic tool for the intravascular assessment of arterial lesions in the equine pulmonary artery.

FY 2015-16

Summary
Approximately 80% of all racehorses can be expected to develop Exercise-Induced Pulmonary Haemorrhage (EIPH) during their career. The diagnosis and treatment of EIPH is estimated to exceed $100 million annually in the United States alone. Currently there are no diagnostic strategies or technologies available for the detection or treatment of this debilitating and costly pathology. Current research by the author and collaborators has indicated a link between this pathology and calcification of the pulmonary artery of affected horses. Not surprisingly, arterial calcification is the most important cause of vascular stiffness in humans. This proposal aims to investigate the feasibility of adapting a novel catheter instrumentation technology, developed by Transonic Scisense, London, ON to identify this pathology. It is expected that Transonic Scisense's technology will be able to register a difference between healthy arterial tissue and the calcified tissue. It is the goal of this project to attempt to use the Transonic Scisense technology for both the early detection and subsequent monitoring of arterial calcification in the equine pulmonary artery. The technical challenges to be addressed by this proposal are: 1) The adaptation of the Transonic Scisense technology for a never-tried application. 2) Development of a minimally invasive surgical protocol that will accurately deliver the Transonic Scisense catheter to the equine pulmonary artery. This project will link an active cardiovascular research group with expertise in arterial biomechanics, modeling and testing, medical tool design and development, clinical treatment and surgical expertise with an industrial collaborator with novel instrumentation technology, design experience, prototyping and manufacturing facilities. It is expected that successful completion of the project will lead to future collaboration with the goal of introducing clinical diagnostic therapies and products for the market.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
488328-2015
Name nom
Runciman, John
Department département
Engineering, School of
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24557
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
1
Nb partie
1
Application title
Proof of concept of a clinical diagnostic tool for the intravascular assessment of arterial lesions in the equine pulmonary artery.
Keyword
NSERC
Application summary
Approximately 80% of all racehorses can be expected to develop Exercise-Induced Pulmonary Haemorrhage (EIPH) during their career. The diagnosis and treatment of EIPH is estimated to exceed $100 million annually in the United States alone. Currently there are no diagnostic strategies or technologies available for the detection or treatment of this debilitating and costly pathology. Current research by the author and collaborators has indicated a link between this pathology and calcification of the pulmonary artery of affected horses. Not surprisingly, arterial calcification is the most important cause of vascular stiffness in humans. This proposal aims to investigate the feasibility of adapting a novel catheter instrumentation technology, developed by Transonic Scisense, London, ON to identify this pathology. It is expected that Transonic Scisense's technology will be able to register a difference between healthy arterial tissue and the calcified tissue. It is the goal of this project to attempt to use the Transonic Scisense technology for both the early detection and subsequent monitoring of arterial calcification in the equine pulmonary artery. The technical challenges to be addressed by this proposal are: 1) The adaptation of the Transonic Scisense technology for a never-tried application. 2) Development of a minimally invasive surgical protocol that will accurately deliver the Transonic Scisense catheter to the equine pulmonary artery. This project will link an active cardiovascular research group with expertise in arterial biomechanics, modeling and testing, medical tool design and development, clinical treatment and surgical expertise with an industrial collaborator with novel instrumentation technology, design experience, prototyping and manufacturing facilities. It is expected that successful completion of the project will lead to future collaboration with the goal of introducing clinical diagnostic therapies and products for the market.